Ketotifen fumarate ophthalmic - Novartis Ophthalmics

Drug Profile

Ketotifen fumarate ophthalmic - Novartis Ophthalmics

Alternative Names: Zaditen; Zaditor; Zatiden

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novartis Ophthalmics
  • Class Antiallergics; Piperidines; Sedating antihistamines; Small molecules; Thiophenes
  • Mechanism of Action Histamine receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Allergic conjunctivitis

Most Recent Events

  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
  • 08 Aug 2013 Biomarkers information updated
  • 18 Oct 2004 Launched as a 0.05% formulation for Allergic conjunctivitis in Japan (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top